Research and Development

A round-up of recent developments in the clinical research arena includes an expansion for NexMed’s pre-clinical division, acquisitions for Medpace …

The recently retired head of Roche’s pharma division has called for more public-private partnerships in the pharma industry. William Burns …

Sanofi-Aventis has signed a deal with a US biotech firm to develop a new treatment which could restore patients’ ability …

Contract research organisation ICON is to team up with Tigermed Consulting, a clinical services company based in China. The alliance …

Roche has promoted Dr Frank Pitzer to chief executive for its Madison, US headquartered genomics business NimbleGen. Dr Pitzer has …

Unblinding is only done when it is deemed essential for the patients by the subject’s physician or a regulatory body, …

Faced with recessionary pressures, ageing populations, and increasingly expensive therapies, governments are redoubling their efforts to contain healthcare costs. Biologics …

Sir James Black, the British physician and pharmacologist who discovered some of the biggest breakthroughs in medicine in the 20th …

Pfizer has disclosed in full the payments it has made to US doctors to conduct clinical trials and to promote …

Celerion has completed the acquisition of MDS Pharma Services’ early-stage development and regulatory services business, marking the latter’s exit from …

Glenn Kerkhof, Chiltern CEO, stated, “Chiltern’s decision to invest in Endpoint is representative of our commitment to seek collaborations which …

GlaxoSmithKline has forged a new strategic alliance with Isis Pharmaceuticals to exploit the specialist company’s expertise in anti-RNA therapeutics. California-based …

Boehringer Ingelheim is to tap into commercial opportunities in emerging technology by launching its own venture capital business. The Boehringer …

Eli Lilly has expanded a clinical trial materials supply agreement with Thermo Fisher Scientific in yet another deal that sees …

This week’s round-up of news in the contract research arena includes a fundraising for Irish CRO Venn Life Sciences, ISO …